Rank #1276KROS

Keros Therapeutics, Inc.

$16.55

2.35% (Daily)

Market Cap

$504.21M

Revenue

$246.72M

Rank by MCap

#1276

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Jasbir S. Seehra Ph.D.

Headquarters

Lexington, MA

Employees

About Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in ...